Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
NCT07317154
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Respiratory Papillomatosis
Interventions
BIOLOGICAL:
Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell
Sponsor
Mayo Clinic